Orchid Pharma Limited has informed the Exchange regarding a press release dated February 19, 2025, titled "Orchid Pharma's Alathur API facility successfully completes USFDA inspection, maintaining its position as India's only USFDA approved facility for Sterile Cephalosporins.".